Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K2 Gold Corp | 23K | Nov 22, 2024 | 0.06 | +0.85 |
K2A KNAUST+ANDERSSON B | F70 | Nov 22, 2024 | 0.86 | 0.00 |
K9 Gold | 5GP0 | Nov 22, 2024 | 0.03 | -17.46 |
K92 Mining Inc | 92K | Nov 22, 2024 | 6.46 | +3.86 |
KA SHUI INTL | MI8 | Nov 22, 2024 | 0.01 | -56.25 |
Kadant, Inc. | KDA | Nov 22, 2024 | 388.00 | +4.86 |
Kaga Electronics Co. Ltd | 9V2 | Nov 22, 2024 | 16.50 | 0.00 |
Kagome Co Ltd Ordinary Shares (Japan) | 5EW | Nov 22, 2024 | 18.50 | +1.65 |
Kainos Group Plc | 1KG | Nov 22, 2024 | 9.45 | +2.16 |
Kairos Minerals Limited | YAJ | Nov 22, 2024 | 0.01 | +7.14 |
Kaiser Aluminum Corporation | KLU1 | Nov 22, 2024 | 75.00 | -4.46 |
Kaiser Reef Limited | 7YR | Nov 22, 2024 | 0.09 | 0.00 |
Kajima Corporation | KAJ | Nov 22, 2024 | 16.50 | +2.48 |
KaKaKu.com, Inc | KKC | Nov 22, 2024 | 14.30 | +5.15 |
Kala Pharmaceuticals | 27F0 | Nov 22, 2024 | 6.22 | +8.73 |
Kalamazoo Resources Limited | KR1 | Nov 22, 2024 | 0.04 | +1.40 |
Kalbe Farma Tbk | LCLA | Nov 22, 2024 | 0.08 | +2.53 |
KALI METALS ORD.F.P. O.N. | 6OB | Nov 22, 2024 | 0.07 | +0.72 |
Kalina Power LImited | WHS | Nov 22, 2024 | 0.00 | 0.00 |
KALMAR OYJ B | XK2 | Nov 22, 2024 | 31.34 | +3.91 |
Kalo Gold Corp | 0SX0 | Nov 22, 2024 | 0.01 | -40.00 |
Kalray SA | 3FS | Nov 22, 2024 | 1.01 | +7.92 |
Kaltura Inc | 73Q | Nov 22, 2024 | 1.98 | -3.88 |
KalVista Pharmaceuticals, Inc. | 4XC1 | Nov 22, 2024 | 8.65 | +2.98 |
Kamux | 4K8 | Nov 22, 2024 | 3.15 | -0.32 |
Kanabo Group Plc | 3WD | Nov 22, 2024 | 0.00 | 0.00 |
Kanamic Network Co. Ltd | 0WT | Nov 22, 2024 | 2.96 | 0.00 |
Kancera | 3EE0 | Nov 22, 2024 | 0.07 | +0.15 |
Kandenko Co. Ltd. | 5EY | Nov 22, 2024 | 13.60 | +1.49 |
Kaneka Corporation | KKA | Nov 22, 2024 | 20.40 | +3.03 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.